Shanghai Serum Bio-Technology Co. Ltd. A (688163.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE1000059X8
Shanghai Serum Bio-Technology Co. Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 194.92 m CNY | 196.21 m CNY |
| Gross profit | 152.15 m CNY | 153.28 m CNY |
| Operating income | 53.39 m CNY | 54.86 m CNY |
| EBIT | 51.00 m CNY | 64.39 m CNY |
| Net income | 44.29 m CNY | 51.79 m CNY |
| Diluted EPS – continuing operations | 0.41 CNY | 0.48 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shanghai Serum Bio-Technology Co. Ltd. A
Shanghai Serum Bio-Technology Co., Ltd. engages in research, development, production, operation, and sales of antitoxin and antivenom serum products for biotoxins and biosafety in China. It offers equine anti-tetanus immunoglobulin, antivenom, and anti-rabies serum products. The company also engaged in the collection and sale of animal immune plasma. The company was founded in 1999 and is based in Shanghai, China.
More stocks
- Client Service International Inc (300663.SZ)
- Lion Capital S.A. (LION.RO)
- Zhejiang Yingfeng Technology Co Ltd (605055.SS)
- China Oil HBP Science & Technology Co Ltd (002554.SZ)
- Jiangsu Teeyer Intelligent Equipment Co.,Ltd. (603273.SS)
- Bichamp Cutting Technology Hunan Co Ltd (002843.SZ)
- Compagnie du Bois Sauvage SA (COMB.BR)
- SUNIC SYSTEM Co. Ltd (171090.KQ)
- Taiwan Sakura Corp (9911.TW)
- CITIZENS & NORTHERN CORP (CZNC)
- Italian Exhibition Group SpA (IEG.MI)
- FDCTECH, INC. (FDCT)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.